AMGEN TO PRESENT NEW RESEARCH FROM ONCOLOGY PORTFOLIO AND PIPELINE AT ESMO 2023

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the presentation of new data across its broad oncology portfolio and pipeline at the European Society for...

Related Keywords

Madrid ,Spain ,Puerto Rico ,United States ,Granada ,Andalucísp ,Barcelona ,Comunidad Autonoma De Cataluna ,France ,Spanish ,French ,America ,Stevens Johnson ,Jessica Akopyan ,Justin Claeys ,Amgen ,Beigene Ltd ,Youtube ,World Best Companies ,World Health Organization ,Chemocentryx Inc ,Teneobio Inc ,Instagram ,Drug Administration On ,Kyowa Kirin Co Ltd ,Linkedin ,European Society For Medical Oncology ,Twitter ,Xencor Inc ,Drug Administration ,Exchange Commission ,Results From Phase ,Highlight Potential ,Patients With Previously Treated ,Data Support ,Stage Results ,Illustrate Expanding Potential ,T Cell Engagers ,European Society ,Medical Oncology ,Presidential Symposium Oral Presentation ,Proffered Paper Oral Session ,Presentation Times ,Madrid Auditorium ,Sevilla Auditorium ,Results From ,Granada Auditorium ,Gastroesophageal Junction Cancer ,Onsite Poster ,Non Small Cell Lung Cancer ,Barcelona Auditorium ,Supplemental New Drug Application ,Prescription Drug User Fee Act ,Advanced Colorectal Cancer ,Safety Information ,Lung Disease ,Common Adverse Reactions ,Dow Jones Industrial Average ,United States Today ,Horizon Therapeutics ,